Literature DB >> 16382099

International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.

William A Catterall1, Edward Perez-Reyes, Terrance P Snutch, Joerg Striessnig.   

Abstract

The family of voltage-gated calcium channels serves as the key transducers of cell surface membrane potential changes into local intracellular calcium transients that initiate many different physiological events. There are 10 members of the voltage-gated calcium channel family that have been characterized in mammals, and they serve distinct roles in cellular signal transduction. This article presents the molecular relationships and physiological functions of these calcium channel proteins and provides comprehensive information on their molecular, genetic, physiological, and pharmacological properties.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16382099     DOI： 10.1124/pr.57.4.5

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


  446 in total

1.  Cav1.3 calcium channels are required for normal development of the auditory brainstem.

Authors:  Jan J Hirtz; Michael Boesen; Nadine Braun; Joachim W Deitmer; Florian Kramer; Christian Lohr; Britta Müller; Hans Gerd Nothwang; Jörg Striessnig; Stefan Löhrke; Eckhard Friauf
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  Association of the α(2)δ(1) subunit with Ca(v)3.2 enhances membrane expression and regulates mechanically induced ATP release in MLO-Y4 osteocytes.

Authors:  William R Thompson; Amber S Majid; Kirk J Czymmek; Albert L Ruff; Jesús García; Randall L Duncan; Mary C Farach-Carson
Journal:  J Bone Miner Res       Date:  2011-09       Impact factor: 6.741

3.  Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.

Authors:  Zhen Zhi Tang; Viktor Yarotskyy; Lan Wei; Krzysztof Sobczak; Masayuki Nakamori; Katy Eichinger; Richard T Moxley; Robert T Dirksen; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2011-12-02       Impact factor: 6.150

4.  AKAP79/150 impacts intrinsic excitability of hippocampal neurons through phospho-regulation of A-type K+ channel trafficking.

Authors:  Lin Lin; Wei Sun; Faith Kung; Mark L Dell'Acqua; Dax A Hoffman
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

5.  Involvement of protein kinase C and protein kinase A in the enhancement of L-type calcium current by GABAB receptor activation in neonatal hippocampus.

Authors:  J G Bray; M Mynlieff
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

6.  Polarised localisation of the voltage-gated sodium channel Na(v)1.2 in cerebellar granule cells.

Authors:  José Martínez-Hernández; Carmen Ballesteros-Merino; Laura Fernández-Alacid; Joel C Nicolau; Carolina Aguado; Rafael Luján
Journal:  Cerebellum       Date:  2013-02       Impact factor: 3.847

7.  Touch responsiveness in zebrafish requires voltage-gated calcium channel 2.1b.

Authors:  Sean E Low; Ian G Woods; Mathieu Lachance; Joel Ryan; Alexander F Schier; Louis Saint-Amant
Journal:  J Neurophysiol       Date:  2012-04-04       Impact factor: 2.714

8.  Nerve terminal nicotinic acetylcholine receptors initiate quantal GABA release from perisomatic interneurons by activating axonal T-type (Cav3) Ca²⁺ channels and Ca²⁺ release from stores.

Authors:  Ai-Hui Tang; Miranda A Karson; Daniel A Nagode; J Michael McIntosh; Victor N Uebele; John J Renger; Matthias Klugmann; Teresa A Milner; Bradley E Alger
Journal:  J Neurosci       Date:  2011-09-21       Impact factor: 6.167

Review 9.  Trafficking and stability of voltage-gated calcium channels.

Authors:  Brett A Simms; Gerald W Zamponi
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

10.  CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease.

Authors:  Soosung Kang; Garry Cooper; Sara F Dunne; Brendon Dusel; Chi-Hao Luan; D James Surmeier; Richard B Silverman
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.